RIMLS highlights 2017
Several awards for Peter van de Kraan and his teamPeter van de Kraan and his team obtained several awards in 2017. In this video, they explain what made them so successful.
Several prizes for Jolanda de Vries13 January 2017
During the New Years 2017 event of the Radboud university medical center, Jolanda de Vries was honored by Leon van Halder, chairman of our executive board, with the Radboud Medal.
The Radboud Medal is the highest Radboudumc honor awarded annually to a person who has contributed significantly to the objective of the Radboudumc as top knowledge center for academic medicine and health.
Jolanda de Vries, professor of translational tumor immunology, works at the Department of Tumor Immunology. She established a clinical vaccination program in which tumor-associated antigens loaded on DCs are used to treat both melanoma and colon cancer patients. Major current projects are to translate the DC vaccination into various clinical settings. Recently she and her team obtained a budget of 20 million euros from the national basic health insurance to introducte the experimental treatment with a vaccine that reduced the risk of the recurrence of skin cancer. The treatment will be offered in Nijmegen, Amsterdam, Rotterdam and Zwolle and is led by Jolanda de Vries.
12 October 2017
Jolanda de Vries, Department of Tumor Immunology, theme Cancer development and immune defense has been awarded the 2017 Huibregtsen Prize for her work on natural dendritic cell vaccines. This award is given to a research project that is scientifically innovative and benefits society.
Jolanda de Vries investigates the role of dendritic cells in the defence against various forms of cancer and studies the effectiveness of dendritic cell therapy. Dendritic cells play an important role in immune responses. In response to infection or inflammation, and in response to cancer, dendritic cells undergo a complicated maturation process, after which they ultimately present fragments (proteins) from the pathogens or cancer cells to T cells in the lymph nodes. These are the ‘killer cells’ of the immune system. Due to the priming from the dendritic cells, they are able to recognise and attack cancer cells.
About the Huibregtsen Prize (in Dutch).
Film about the research (in Dutch).
List of awards
Cancer development and immune defenseThe Christine Mohrmann Stipendium was awarded to Jorieke Weiden to visit the lab of Prof. Bencherif in Boston, USA.
Cancer development and immune defenseThe Tom Voute Young Investigator Award was granted to René Marke, PhD candidate at the Laboratory of Pediatric Oncology by Kika (KInderen KAnkervrij) for his excellent research in the area of pediatric oncology.
Reconstructive and regenerative medicineThe Young Investigator Award was presented to Roel op ‘t Veld, PhD candidate from dept of Dentistry at the annual conference of the European Tissue Repair Society, held in Brussels.
Renal disordersThe Biodonostia Gastroenterology and Hepatology Award was presented to Joost Drenth in San Sebastian, Spain for his contribution to the research on liver disease and management of patients with liver diseases.
RIMLSThe Hans Bloemendal Medal was endowed to Richard Flavell, Yale University (USA), in recognition of his groundbreaking studies on immunobiology.